ADVM
Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
时间:2024-11-21 05:05:00 市场: 美股 综合
Adverum Biotechnologies Inc: 6E10 Dose in Luna Maintains Visual and Anatomic Endpoints
时间:2024-11-18 20:03:16 市场: 美股 综合
Adverum Biotechnologies Inc: Expects to Be Able to Fund Operations Into Second Half of 2025
时间:2024-11-18 20:03:16 市场: 美股 综合
Adverum Biotechnologies Inc: Appointed Jason Mitchell as Chief Commercial Officer
时间:2024-11-05 05:39:45 市场: 美股 综合
Adverum Biotechnologies Inc: on Track to Initiate Pivotal Program in 1H 2025
时间:2024-11-05 05:39:45 市场: 美股 综合